Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539637 | NSE Symbol : | ISIN : INE562S01013 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
20-May-2025	29-May-2025	Accounts	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Blueblood Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Audited Standalone Financials Results of the Company for the half and Financial year ended 31st March2025 Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The Standalone Annual Audited Financial Results for the Financial Year 2024-2025 along with Auditors Report thereon had been approved by the Board of Directors of the Company in its meeting held on 29th day of May,2025 and the said meeting commenced at 04:55 P.M. and Concluded at 05:30 P.M (As Per BSE Announcement Dated on: 29/05/2025)
07-Nov-2024	14-Nov-2024	Half Yearly Results	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Thursday 14th Day of November 2024 to consider and approve inter-alias the Un-Audited Standalone Financial Results for the Second Quarter and half year ended 30th September 2024. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements)Regulations, 2015, the half year and Financial Year ended 30th September 2024 of the Company at its meeting held on 14th November 2024 and the said meeting commenced at 15:30 P.M. and concluded at 17:05 P.M (As per BSE Announcement Dated on 14/11/2024) Please find enclosed herewith Standalone un-audited Financials Results of our company correcting the discrepancy ' Bifurcation of Trade payables not provided as per Acounting Standard Division I format for Half Year ended September-2024. Revised Financials are enclosed herewith (As per BSE Announcement Dated on 17/12/2024)
01-Oct-2024	10-Oct-2024	Change in Registered Address	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2024 inter alia to consider and approve Change of Registered office Address of the Company from its Present Location to M-55 3RD FLOOR M-BLOCK MARKET GREATER KAILASH-II NEW DELHI-110048 Notice is hereby given pursuant to Regulation 30 of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 that a meeting of Board of Directors of the company was held on Thursday, the 10th day of October, 2024 on 12:30 P.M at M-55, 3RD Floor, M Block Market, Greater Kailash-II New Delhi-110048 to consider and approve inter- alia, the change of registered address of the company from P-27, Malviya Nagar, Main Market, New Delhi, India-110017 to M-55, 3rd Floor, M Block Market Greater Kailash-II, New Delhi-110048. Read less.. (As Per BSE Announcement Dated on 10.10.2024)
07-Sep-2024	07-Sep-2024	AGM	The Board of Directors at their meeting held on Saturday 07th September, 2024 has decided the following: Annual General Meeting of the Company will be held on Monday, the 30th September, 2024 at 11:30 A.M. at M-55 M Block Market, Greater Kailash-2, Top Floor, New Delhi-110048.
18-May-2024	27-May-2024	Accounts	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve The Audited Standalone Financials Results for the Company of the half and Financial Year ended 13st March2024 and to approve the Resignation of Mr. Pushpendra Surana. Pursuant to Regulation 33 of the Securities Exchange Board of India ( Listing Obligations and Disclosures Requirements ) Regulations 2015, the Standalone Annual Audited Financials Results for the Financial Year Ended 2023-24 along with Auditor Report thereon has been approved by the Board of Directors of the Company in its meeting held on 27th day of May,2024 and the said meeting commenced at 03:30 P.M. and Concluded at 05:45 P.M. (As Per BSE Announcement Dated on 27.05.2024)
02-Nov-2023	14-Nov-2023	Quarterly Results	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Tuesday 14th Day of November 2023 to consider and approve inter-alias the Un-Audited Standalone Financial Results for the Second Quarter and half year ended 30th September 2023. Pursuant to Regulation 33 of the SEBI(listing Obligations and Disclosure Requirements) Regulations, 2015, the Half year and Financial year ended 30th September 2023 of the Company at its meeting help on 14th November 2023 and the said meeting commenced at 13:00 P.M. and Concluded at 14:30 P.M.. (As per BSE Announcement Dated on 14/11/2023) Pursuant to Regulation 33 of the SEBI(Listing Obligations and Disclosures Requirements), Regulations 2015, the Half-year end and Financial year ended 30th September,2023, the Company filed revised financials rectifying the discrepancy 'Bifurcation of Trade Payables not provided as per Accounting standard division 1 format for the Half Year ended 30th September,2023 (As per BSE Announcement Dated on 08/01/2025)
07-Sep-2023	07-Sep-2023	AGM	Outcome of the Board Meeting held on 07.09.2023 relating to Approval for convening of the Annual General Meeting of the Company.
22-May-2023	29-May-2023	Quarterly Results	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Inter-alia the Unaudited Standalone Financial Results for the Company of the half and Financial year ended 31st March 2023. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the following documents for the Half Year and Financial Year ended 31st March 2023 as reviewed by the Audit Committee which have been approve by the Board of Director of the Company at its meeting held on May 29, 2023 and the said meeting commenced at 12.00 P.M. and concluded at 02.30 P.M. In that meeting the Board has decided the following matters: 1. Standalone Annual Audited Financial Results for the Financial Year 2022-23 along with Auditor Report thereon. 2. A Declaration on Auditors Report with unmodified opinion for Audited Financial Results for the Financial Year 2022-23 (As Per BSE Announcement dated on 29.05.2023)
02-Nov-2022	14-Nov-2022	Half Yearly Results	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Board Meeting Intimation for Notice of Board Meeting Pursuant to Regulation 29 Of SEBI(LODR) 2015. Considered and Approved the Standalone Quarterly and half yearly ended September 30th 2022 Unaudited Financial Results for the Financial Year 2022-23 along with Auditor Report thereon. (As Per BSE Announcement Dated on 14.11.2022)
05-Sep-2022	05-Sep-2022	AGM	Board Meeting Outcome for Outcome Of Board Meeting Held On 05.09.2022 and to Approve the notice and date place and time of Annual General Meeting.
21-May-2022	30-May-2022	Accounts	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Notice of Board Meeting Pursuant to Regulation 29 of SEBI(LODR) 2015. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the following documents for the Half Year and Financial Year ended 31st March 2022 as reviewed by the Audit Committee which have been approve by the Board of Director of the Company at its meeting held on May 30, 2022 and the said meeting commenced at 02.30 P.M. and concluded at 05.30 P.M. In that meeting the Board has decided the following matters: : 1. Standalone Annual Audited Financial Results for the Financial Year 2021-22 along with Auditor Report thereon. 2. A Declaration on Auditors Report with unmodified opinion for Audited Financial Results for the Financial Year 2021-22 (As Per BSE Announcement Dated on 30/05/2022)
07-Dec-2021	06-Dec-2021	AGM	Blueblood Ventures Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 24, 2021 to December 31, 2021 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on December 30, 2021. Outcome of Board Meeting of Blueblood Ventures Limited held on 06th Dec, 2021 (As per BSE Announcement Dated on 6/12/2021)
08-Nov-2021	13-Nov-2021	Half Yearly Results	Half Yearly Results UNAUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEP, 2021 (As Per BSE Announcement dated on 13.11.2021)
18-Jun-2021	28-Jun-2021	Half Yearly Results	Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021 ,inter alia, to consider and approve TO CONSIDER AND APPROVE THE HALF YEARLY RESULTS FOR YEAR ENDED 31ST MARCH, 2021. OUTCOME OF BOARD MEETING (As per BSE Announcement Dated on 28/06/2021)
03-Feb-2021	20-Jan-2021	Change in Directors	RECONSTITUTION OF THE COMMITTEES OF THE BOARD APPOINTMENT OF COMPANY SECRETARY/ COMPLIANCE OFFICER OF THE COMPANY

1 2

LOGIN HERE

Blueblood Ventures Ltd

Board Meeting